• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[对风湿性疾病患者而言,实现对麻疹的完全免疫是否是一个现实的目标,以及如何才能实现这一目标?]

[Is complete immunity against measles a realistic target for patients with rheumatic diseases and how can it possibly be achieved?].

作者信息

Braun J, Kiltz U, Müller-Ladner U

机构信息

Rheumazentrum Ruhrgebiet, Herne und Ruhr-Universität Bochum, Claudiusstr 45, 44649, Herne, Deutschland.

St. Elisabeth Gruppe GmbH, Herne, Deutschland.

出版信息

Z Rheumatol. 2020 Nov;79(9):922-928. doi: 10.1007/s00393-020-00877-1. Epub 2020 Sep 18.

DOI:10.1007/s00393-020-00877-1
PMID:32945951
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7647971/
Abstract

Measles outbreaks occur rather frequently in Germany. Patients with chronic inflammatory diseases are often treated with immunosuppressants. A recent study showed that about 7% of such patients are not protected against measles according to the lack of documentation in the vaccination card or the absence of protective antibodies. The Standing Committee on Immunization (STIKO) recommends a first vaccination against measles as a measles-mumps-rubella combined vaccination (MMR) in children aged 11-14 months and a second vaccination at 14-23 months. For adults born after 1970, vaccination against measles is recommended if they have not yet been vaccinated against measles or have only been vaccinated once against measles or if their vaccination status is unclear. In April 2019, STIKO published instructions for vaccinations recommended for immunodeficiency. Since March 1, 2020, measles vaccination have been compulsory in Germany.

摘要

德国麻疹疫情相当频繁地发生。患有慢性炎症性疾病的患者经常接受免疫抑制剂治疗。最近一项研究表明,根据疫苗接种卡上缺乏记录或缺乏保护性抗体,约7%的此类患者对麻疹没有免疫力。免疫接种常务委员会(STIKO)建议,在11至14个月大的儿童中首次接种麻疹疫苗,采用麻疹-腮腺炎-风疹联合疫苗(MMR),并在14至23个月时进行第二次接种。对于1970年以后出生的成年人,如果他们尚未接种过麻疹疫苗、仅接种过一次麻疹疫苗或其疫苗接种状况不明,则建议接种麻疹疫苗。2019年4月,STIKO发布了针对免疫缺陷推荐疫苗接种的指导意见。自2020年3月1日起,德国实行麻疹疫苗强制接种。

相似文献

1
[Is complete immunity against measles a realistic target for patients with rheumatic diseases and how can it possibly be achieved?].[对风湿性疾病患者而言,实现对麻疹的完全免疫是否是一个现实的目标,以及如何才能实现这一目标?]
Z Rheumatol. 2020 Nov;79(9):922-928. doi: 10.1007/s00393-020-00877-1. Epub 2020 Sep 18.
2
Influences on immunization rates: Vaccination coverage of mumps, measles, rubella and varicella before and after the STIKO intervention 2011 - A retrospective study.对免疫接种率的影响:2011年德国常设疫苗委员会(STIKO)干预前后腮腺炎、麻疹、风疹和水痘的疫苗接种覆盖率——一项回顾性研究。
Vaccine. 2016 Jul 25;34(34):3938-41. doi: 10.1016/j.vaccine.2016.06.027. Epub 2016 Jun 16.
3
Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.孟加拉国儿童中麻疹、腮腺炎和风疹IgG抗体的流行率:一项评估综合疫苗接种策略必要性的试点研究。
Scand J Immunol. 2006 Dec;64(6):684-9. doi: 10.1111/j.1365-3083.2006.01857.x.
4
[Epidemiological analysis of immunity against vaccine-preventable diseases: rubella, measles, mumps and chickenpox].[疫苗可预防疾病的免疫情况流行病学分析:风疹、麻疹、腮腺炎和水痘]
Dtsch Med Wochenschr. 2001 Nov 16;126(46):1289-93. doi: 10.1055/s-2001-18475.
5
[Experience with preventive measles, mumps and rubella vaccination in unified Germany].[德国统一后麻疹、腮腺炎和风疹预防接种的经验]
Gesundheitswesen. 1993 Jan;55(1):38-9.
6
Seroprevalence of antibodies to measles, mumps, and rubella, and serologic responses after vaccination among human immunodeficiency virus (HIV)-1 infected adults in Northern Thailand.泰国北部感染人类免疫缺陷病毒(HIV)-1的成年人中麻疹、腮腺炎和风疹抗体的血清流行率以及接种疫苗后的血清学反应。
BMC Infect Dis. 2016 Apr 30;16:190. doi: 10.1186/s12879-016-1499-x.
7
Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).预防麻疹、风疹、先天性风疹综合征和流行性腮腺炎,2013 年:免疫实践咨询委员会(ACIP)的总结建议。
MMWR Recomm Rep. 2013 Jun 14;62(RR-04):1-34.
8
Long-term immunogenicity of measles, mumps and rubella-containing vaccines in healthy young children: A 10-year follow-up.含麻疹、腮腺炎和风疹疫苗在健康幼儿中的长期免疫原性:10 年随访。
Vaccine. 2019 Aug 23;37(36):5323-5331. doi: 10.1016/j.vaccine.2019.07.049. Epub 2019 Jul 22.
9
Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants.骨髓移植儿童接种MMR疫苗后对麻疹、腮腺炎和风疹的长期免疫力。
Bone Marrow Transplant. 2004 Jun;33(12):1187-90. doi: 10.1038/sj.bmt.1704476.
10
Similar Antibody Levels in 3-Year-Old Children Vaccinated Against Measles, Mumps, and Rubella at the Age of 12 Months or 18 Months.12个月或18个月大时接种麻疹、腮腺炎和风疹疫苗的3岁儿童体内抗体水平相似。
J Infect Dis. 2016 Jun 15;213(12):2005-13. doi: 10.1093/infdis/jiw058. Epub 2016 Feb 9.

引用本文的文献

1
[Immunosuppressed people's beliefs, expectations, and experiences with COVID-19 vaccinations : Results of a longitudinal study].[免疫抑制人群对新冠疫苗接种的信念、期望及经历:一项纵向研究的结果]
Z Rheumatol. 2023 May;82(4):342-354. doi: 10.1007/s00393-022-01213-5. Epub 2022 May 6.

本文引用的文献

1
[How well are patients with inflammatory rheumatic diseases protected against measles?].炎症性风湿疾病患者对麻疹的防护效果如何?
Z Rheumatol. 2020 Nov;79(9):912-921. doi: 10.1007/s00393-020-00874-4. Epub 2020 Sep 15.
2
Live attenuated MMR/V booster vaccines in children with rheumatic diseases on immunosuppressive therapy are safe: Multicenter, retrospective data collection.免疫抑制治疗的风湿性疾病患儿使用减毒活疫苗(MMR/V)加强疫苗是安全的:多中心回顾性数据收集。
Vaccine. 2020 Feb 24;38(9):2198-2201. doi: 10.1016/j.vaccine.2020.01.037. Epub 2020 Jan 24.
3
Vaccination rate and immunity of children and adolescents with inflammatory bowel disease or autoimmune hepatitis in Germany.德国炎症性肠病或自身免疫性肝炎儿童和青少年的疫苗接种率和免疫情况。
Vaccine. 2020 Feb 11;38(7):1810-1817. doi: 10.1016/j.vaccine.2019.12.024. Epub 2019 Dec 24.
4
Incidence and prevalence of vaccine preventable infections in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD): a systemic literature review informing the 2019 update of the EULAR recommendations for vaccination in adult patients with AIIRD.成人自身免疫性炎症性风湿病(AIIRD)患者疫苗可预防感染的发病率和患病率:系统文献回顾,为 2019 年 AIIRD 成人患者疫苗接种 EULAR 建议更新提供信息。
RMD Open. 2019 Sep 19;5(2):e001041. doi: 10.1136/rmdopen-2019-001041. eCollection 2019.
5
Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations.成人自身免疫性炎症性风湿病患者疫苗接种的疗效、免疫原性和安全性:2019 年 EULAR 建议更新的系统文献回顾。
RMD Open. 2019 Sep 9;5(2):e001035. doi: 10.1136/rmdopen-2019-001035. eCollection 2019.
6
2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases.2019 年更新版:欧洲抗风湿病联盟成人自身免疫性炎症性风湿病患者疫苗接种推荐。
Ann Rheum Dis. 2020 Jan;79(1):39-52. doi: 10.1136/annrheumdis-2019-215882. Epub 2019 Aug 14.
7
[Not Available].[不可用]。
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2019 Apr;62(4):494-515. doi: 10.1007/s00103-019-02905-1.
8
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors).ESCMID 研究组(ESGICH)对有合并症宿主感染的共识文件:靶向和生物治疗的安全性:传染病学视角(可溶性免疫效应分子[II]:针对白细胞介素、免疫球蛋白和补体因子的药物)。
Clin Microbiol Infect. 2018 Jun;24 Suppl 2:S21-S40. doi: 10.1016/j.cmi.2018.02.002. Epub 2018 Feb 12.
9
Safety of live vaccines on immunosuppressive or immunomodulatory therapy-a retrospective study in three Swiss Travel Clinics.免疫抑制或免疫调节治疗下活疫苗的安全性:瑞士三家旅行诊所的回顾性研究。
J Travel Med. 2018 Jan 1;25(1). doi: 10.1093/jtm/tax082.
10
[Not Available].[无可用内容]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 Jun;60(6):674-684. doi: 10.1007/s00103-017-2555-4.